MA28985B1 - Analogues de loxapine et methodes d'utilisation - Google Patents
Analogues de loxapine et methodes d'utilisationInfo
- Publication number
- MA28985B1 MA28985B1 MA29765A MA29765A MA28985B1 MA 28985 B1 MA28985 B1 MA 28985B1 MA 29765 A MA29765 A MA 29765A MA 29765 A MA29765 A MA 29765A MA 28985 B1 MA28985 B1 MA 28985B1
- Authority
- MA
- Morocco
- Prior art keywords
- methods
- loxapine
- analogues
- relates
- novel compounds
- Prior art date
Links
- XJGVXQDUIWGIRW-UHFFFAOYSA-N loxapine Chemical class C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=CC=C(Cl)C=C12 XJGVXQDUIWGIRW-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61184904P | 2004-09-21 | 2004-09-21 | |
| US67319805P | 2005-04-19 | 2005-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28985B1 true MA28985B1 (fr) | 2007-11-01 |
Family
ID=36090680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA29765A MA28985B1 (fr) | 2004-09-21 | 2007-03-20 | Analogues de loxapine et methodes d'utilisation |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US7592333B2 (enExample) |
| EP (1) | EP1804804B1 (enExample) |
| JP (1) | JP5049129B2 (enExample) |
| KR (1) | KR101264444B1 (enExample) |
| AT (1) | ATE542536T1 (enExample) |
| AU (1) | AU2005286713B2 (enExample) |
| BR (1) | BRPI0515518A (enExample) |
| CA (1) | CA2580250C (enExample) |
| CY (1) | CY1112590T1 (enExample) |
| DK (1) | DK1804804T3 (enExample) |
| EA (1) | EA012610B1 (enExample) |
| ES (1) | ES2378452T3 (enExample) |
| MA (1) | MA28985B1 (enExample) |
| MX (1) | MX2007003032A (enExample) |
| NO (1) | NO20071604L (enExample) |
| NZ (1) | NZ553900A (enExample) |
| PL (1) | PL1804804T3 (enExample) |
| PT (1) | PT1804804E (enExample) |
| WO (1) | WO2006034414A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| MXPA05007784A (es) * | 2003-01-23 | 2005-09-30 | Acadia Pharm Inc | Empleo de la n-desmetilclozapina para tratar las enfermedades neuropsiquiatricas humanas. |
| PT1696931E (pt) * | 2003-12-22 | 2009-06-12 | Acadia Pharm Inc | Análogos diaril[a,d]ciclo-hepteno substituídos com amino utilizados como agonistas muscarínicos e métodos de tratamento de perturbações neuropsiquiátricas |
| MXPA06011320A (es) * | 2004-04-01 | 2007-03-21 | Acadia Pharm Inc | Metodo de sintesis y aislamiento de n-desmetilclozapina solida y sus formas cristalinas. |
| WO2006049734A2 (en) * | 2004-10-29 | 2006-05-11 | Hypnion, Inc. | Quetiapine analogs and methods of use thereof |
| WO2007053618A1 (en) * | 2005-10-31 | 2007-05-10 | Acadia Pharmaceuticals Inc. | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| US7762006B2 (en) * | 2006-06-14 | 2010-07-27 | Siestamed, Technologies | Medical equipment drying device |
| RU2459811C2 (ru) * | 2006-10-28 | 2012-08-27 | Метилджен Инк. | Ингибиторы гистоновой деацетилазы |
| BRPI0808828A8 (pt) * | 2007-03-15 | 2017-11-28 | Aryx Therapeutics Inc | Compostos de dibenzo[b,f][1,4]oxazapina |
| US8827979B2 (en) | 2007-03-19 | 2014-09-09 | Insuline Medical Ltd. | Drug delivery device |
| US9220837B2 (en) | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
| US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
| EP2231229A1 (en) | 2007-12-18 | 2010-09-29 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
| CN102245137A (zh) | 2008-11-07 | 2011-11-16 | 茵苏莱恩医药有限公司 | 用于药物递送的装置和方法 |
| WO2014116684A1 (en) * | 2013-01-22 | 2014-07-31 | Edward Roberts | Non-peptidic neuropeptide y receptor modulators |
| CN107635549A (zh) | 2015-03-26 | 2018-01-26 | 杰奎琳·M·艾弗森 | 抑制与宿醉相关的症状的方法和组合物 |
| AU2020370063B2 (en) * | 2019-10-21 | 2025-10-23 | Alairion, Inc. | 3-(4-(11H-dibenzo[b,e][1,4]azepin-6-yl)piperazin-1-yl)- and 3-(4-(dibenzo[b,f][1,4]oxazepin/thiazepin/diazepin-11-yl)piperazin-1-yl)-propanoic acid derivatives as H1 and 5-HT2A-receptor modulators for the treatment of sleep disorders |
| WO2025076527A1 (en) * | 2023-10-07 | 2025-04-10 | Inspire Medical Systems, Inc. | Pulmonary therapy for sleep disordered breathing care |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140242B (nl) | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
| US3928356A (en) | 1967-10-06 | 1975-12-23 | Fujisawa Pharmaceutical Co | 10-{8 4-({107 -Hydroxy alkyl)-1-piperazimyl{9 -dibenzo (h,f) oxofins and thiepins and acetyl esters thereof |
| NL7110453A (enExample) | 1970-08-06 | 1972-02-08 | Wander Ag Dr A | |
| US4072756A (en) | 1973-05-17 | 1978-02-07 | Sandoz Ltd. | Tricyclo piperidino ketones and soporific compositions thereof |
| US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| JPH04211071A (ja) * | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
| US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
| ATE208615T1 (de) | 1993-07-09 | 2001-11-15 | Scherer Corp R P | Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen |
| US5616344A (en) | 1994-06-14 | 1997-04-01 | Fuisz Technologies Ltd. | Apparatus and process for strengthening low density compression dosage units and product therefrom |
| US5622719A (en) | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
| US5895664A (en) | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
| US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| AR008371A1 (es) | 1996-05-30 | 2000-01-19 | Novartis Ag | Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ |
| WO1998036738A1 (en) | 1997-02-20 | 1998-08-27 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| US6277406B1 (en) | 1997-10-08 | 2001-08-21 | Fuisz Technologies Ltd. | Easily processed tablet compositions |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US7189757B2 (en) * | 2001-10-16 | 2007-03-13 | Hypnion, Inc. | Treatment of sleep disorders using CNS target modulators |
| US20050049146A1 (en) | 2001-11-05 | 2005-03-03 | Chiarello John F. | Use of substituted dibenzothiepine derivatives as insecticidal, acaricidal and nematicidal agents |
| EP1578198A1 (en) | 2002-12-20 | 2005-09-28 | Basf Aktiengesellschaft | Pesticidal dibenzo(hetero)azepine derivatives |
| US20060063754A1 (en) | 2004-09-21 | 2006-03-23 | Edgar Dale M | Methods of treating a sleep disorder |
-
2005
- 2005-09-21 ES ES05801120T patent/ES2378452T3/es not_active Expired - Lifetime
- 2005-09-21 EP EP05801120A patent/EP1804804B1/en not_active Expired - Lifetime
- 2005-09-21 PT PT05801120T patent/PT1804804E/pt unknown
- 2005-09-21 BR BRPI0515518-5A patent/BRPI0515518A/pt not_active IP Right Cessation
- 2005-09-21 PL PL05801120T patent/PL1804804T3/pl unknown
- 2005-09-21 AU AU2005286713A patent/AU2005286713B2/en not_active Ceased
- 2005-09-21 US US11/233,417 patent/US7592333B2/en not_active Expired - Fee Related
- 2005-09-21 NZ NZ553900A patent/NZ553900A/en not_active IP Right Cessation
- 2005-09-21 WO PCT/US2005/034015 patent/WO2006034414A2/en not_active Ceased
- 2005-09-21 DK DK05801120.6T patent/DK1804804T3/da active
- 2005-09-21 JP JP2007532670A patent/JP5049129B2/ja not_active Expired - Fee Related
- 2005-09-21 AT AT05801120T patent/ATE542536T1/de active
- 2005-09-21 EA EA200700702A patent/EA012610B1/ru not_active IP Right Cessation
- 2005-09-21 CA CA2580250A patent/CA2580250C/en not_active Expired - Fee Related
- 2005-09-21 MX MX2007003032A patent/MX2007003032A/es active IP Right Grant
- 2005-09-21 US US11/232,590 patent/US20060063755A1/en not_active Abandoned
- 2005-09-21 KR KR1020077009122A patent/KR101264444B1/ko not_active Expired - Fee Related
-
2007
- 2007-03-20 MA MA29765A patent/MA28985B1/fr unknown
- 2007-03-27 NO NO20071604A patent/NO20071604L/no not_active Application Discontinuation
-
2009
- 2009-03-25 US US12/411,083 patent/US8101596B2/en not_active Expired - Fee Related
-
2012
- 2012-03-28 CY CY20121100315T patent/CY1112590T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007003032A (es) | 2007-05-21 |
| US7592333B2 (en) | 2009-09-22 |
| NZ553900A (en) | 2010-10-29 |
| EP1804804B1 (en) | 2012-01-25 |
| WO2006034414A2 (en) | 2006-03-30 |
| EA200700702A1 (ru) | 2007-10-26 |
| PT1804804E (pt) | 2012-03-30 |
| US20090186872A1 (en) | 2009-07-23 |
| WO2006034414A3 (en) | 2006-09-08 |
| CY1112590T1 (el) | 2016-02-10 |
| JP5049129B2 (ja) | 2012-10-17 |
| NO20071604L (no) | 2007-06-20 |
| EA012610B1 (ru) | 2009-10-30 |
| PL1804804T3 (pl) | 2012-08-31 |
| AU2005286713A1 (en) | 2006-03-30 |
| EP1804804A2 (en) | 2007-07-11 |
| AU2005286713B2 (en) | 2010-10-28 |
| CA2580250A1 (en) | 2006-03-30 |
| DK1804804T3 (da) | 2012-02-20 |
| KR101264444B1 (ko) | 2013-05-20 |
| EP1804804A4 (en) | 2010-11-24 |
| CA2580250C (en) | 2013-05-14 |
| US20060063928A1 (en) | 2006-03-23 |
| ES2378452T3 (es) | 2012-04-12 |
| US8101596B2 (en) | 2012-01-24 |
| US20060063755A1 (en) | 2006-03-23 |
| KR20070060126A (ko) | 2007-06-12 |
| BRPI0515518A (pt) | 2008-07-29 |
| ATE542536T1 (de) | 2012-02-15 |
| JP2008513510A (ja) | 2008-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28985B1 (fr) | Analogues de loxapine et methodes d'utilisation | |
| WO2006049734A3 (en) | Quetiapine analogs and methods of use thereof | |
| ATE416168T1 (de) | Modulatoren des vanilloidrezeptors | |
| MA28802B1 (fr) | Utilisations therapeutiques d'inhibiteurs de rtp801 | |
| DE60327306D1 (de) | Modifizierter russ | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| EP1810979A4 (en) | STABILIZED HUMAN IgG4 ANTIBODIES | |
| SE0301653D0 (sv) | Novel compounds | |
| AU2003254177A8 (en) | Substituted benzanilides as modulators of the ccr5 receptor | |
| BRPI0411528A (pt) | uso de isomalte como prebiótico | |
| DK1549638T3 (da) | Indol-3-carboxamider som glucokinase (GK) aktivatorer | |
| EP1540015A4 (en) | ASSAYS AND COMPOSITIONS FOR IDENTIFYING THE ACTIVITY OF DEUBIQUITINATING AGENTS MODULATING AGENTS | |
| AU2003256923A8 (en) | Substituted benzanilides as modulators of the ccr5 receptor | |
| EP1638977A4 (en) | SALINOSPORAMIDES AND METHOD OF USE THEREOF | |
| DE60126838D1 (de) | Amidoacetonitrile zur Bekämpfung von Endoparasiten | |
| DE60335716D1 (de) | Beschleuniger-zusammensetzung | |
| IL181445A0 (en) | Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators | |
| DE60324641D1 (de) | Schäumbare Emulsion des Öl-in-Waser-Typs | |
| EP1817055A4 (en) | OVR110 ANTIBODY COMPOSITIONS AND USE PROCEDURES | |
| UY28344A1 (es) | Nuevos compuestos | |
| ATE448234T1 (de) | Olanzapin-analoga und verfahren zu ihrer verwendung | |
| ATE433458T1 (de) | Modulatoren von ship-1 | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| MX2007003398A (es) | Sulfonamidas y sus usos. | |
| EP1809646A4 (en) | GLYCIN RIBOSWITCHE, METHOD FOR THEIR USE AND COMPOSITIONS FOR USE WITH GLYCIN RIBOSWITCHES |